With the impending patent expiries of biologic drugs, there is a huge market potential for subsequent entry biologics. A strong integration of R&D and marketing is key to success, and this briefing will highlight the technology advancements.
Why you should attend:
Learn about the growth of follow-on-biologics
Identify the drivers and restraints
Discuss trends in technology development